GleamWall
中文EN

CCEL CRYO CELL INTERNATIONAL INC

Services-Misc Health & Allied Services, NEC · NYSE · SEC CIK 862692 · Fiscal year ends 11/30

Financial factors as of 2026-08-31 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-2.0%
TTM net income YoY-310.8%
TTM EPS YoY-380.0%
Revenue 3-yr CAGR-0.1%
Net income 3-yr CAGR—

Margins

Gross margin78.5%
Operating margin0.6%
Net margin-6.2%
FCF margin14.9%
EBITDA margin3.4%

Returns

ROE—
ROA-3.1%
ROIC (approx.)—
Asset turnover0.50x

Leverage & solvency

Liabilities / assets126.3%
Debt / equity—
Current ratio0.86x
Interest coverage0.10x

Cash quality & payout

Operating cash flow / net income-2.53x
Accruals ratio-10.9%
Payout ratio—
Capex / revenue0.9%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-11-30FY20242024-11-30
Income statement
Revenue$31.57M$31.99M
Cost of revenue$7.38M$7.95M
Gross profit$24.19M$24.04M
R&D expense$376,263$1.24M
SG&A expense$18.22M$18.52M
Operating income$482,394$3.48M
Interest expense$2.07M$1.86M
Pretax income-$2.34M$2.80M
Income tax$92,232$2.40M
Net income-$2.43M$402,095
EBITDA$1.47M$4.17M
EPS (basic)-0.300.05
EPS (diluted)-0.300.05
Dividends declared per share—0.25
Weighted avg. shares (diluted)8.07M8.21M
Balance sheet
Cash & equivalents$319,031$560,960
Short-term investments$2.98M$2.94M
Receivables$6.85M$7.31M
Inventory$408,794$657,703
Current assets$11.76M$12.55M
PP&E, net$21.03M$21.89M
Goodwill$1.94M$1.94M
Intangibles$863,074$921,254
Total assets$61.73M$64.68M
Current liabilities$19.79M$21.60M
Long-term debt$8.35M$8.48M
Total debt$8.35M$8.48M
Total liabilities$80.33M$77.89M
Shareholders' equity-$18.61M-$13.22M
Net debt$8.03M$7.92M
Shares outstanding8.06M8.08M
Cash flow statement
Operating cash flow$5.48M$6.01M
Capital expenditure$230,475$2.40M
Free cash flow$5.25M$3.61M
Investing cash flow-$975,332-$4.88M
Financing cash flow-$4.75M-$979,118
Depreciation & amortization$985,242$693,847
Stock-based compensation$417,101$781,128
Dividends paid$3.23M$2.02M
Share buybacks$169,502$1.42M

Free plan shows the latest 2 periods; Pro shows all 16 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.